Delayed panel on vaccine injury payments to meet next monthnews2025-11-26T16:44:30+00:00November 26th, 2025|Endpoints News|
Imfinzi’s latest label expansion; FDA seeks more information on BiomX’s nebulizernews2025-11-26T15:30:32+00:00November 26th, 2025|Endpoints News|
FDA pushes back Ascendis’ dwarfism drug decision date by three monthsnews2025-11-26T13:57:06+00:00November 26th, 2025|Endpoints News|
China’s Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturnanews2025-11-26T13:31:07+00:00November 26th, 2025|Endpoints News|
Cormorant eyes another $400M healthcare fundnews2025-11-26T13:02:16+00:00November 26th, 2025|Endpoints News|
Sanofi headquarters raided in broader French tax fraud investigationnews2025-11-26T11:46:20+00:00November 26th, 2025|Endpoints News|
Kallyope scraps one of two mid-stage migraine drugsnews2025-11-26T10:37:29+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second roundnews2025-11-25T23:09:56+00:00November 25th, 2025|Endpoints News|
What a team of ex-Amazon employees are building next in healthcarenews2025-11-25T17:48:16+00:00November 25th, 2025|Endpoints News|
